This inventor holds 5 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC, Msd International Gmbh. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 2,405 
2 out of 72 
1 out of 9 Years Active: 2021-2026
Title: The Innovative Contributions of David Annunziato Candito
Introduction: David Annunziato Candito is an accomplished inventor based in Wrentham, MA, known for his significant contributions to pharmaceutical innovations. With a strong focus on treatments for various diseases, he holds three patents that highlight his dedication to advancing medical science.
Latest Patents: Candito's recent patent work includes groundbreaking inventions aimed at addressing critical health issues. One of his latest patents revolves around PRMT5 inhibitors. This invention provides a compound of Formula (I) and its pharmaceutically acceptable salts, esters, and prodrugs, which are beneficial in the treatment of cancer, sickle cell disease, and hereditary persistence of fetal hemoglobin mutations. Another significant patent focuses on indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors. This invention highlights substituted certain reversed indazole compounds of Formula (I) that serve as potent inhibitors of LRRK2 kinase, useful for treating conditions such as Parkinson's Disease. Candito's innovations also include pharmaceutical compositions utilizing these compounds, significantly impacting the prevention and treatment of related diseases.
Career Highlights: Over the years, David Annunziato Candito has made substantial strides in the pharmaceutical industry. He has worked with renowned companies, including Merck Sharp & Dohme Corporation and MSD International GmbH. His experience in these prominent organizations propelled his research efforts, enabling him to contribute to the development of valuable therapeutic solutions.
Collaborations: Candito's journey in innovation has also involved collaborations with notable professionals in the field. He has worked alongside distinguished colleagues, such as John Acton and J. Michael Ellis, further enriching his research and enhancing the potential impact of his inventions.
Conclusion: David Annunziato Candito’s work exemplifies the spirit of innovation in the pharmaceutical industry. With a focus on developing treatments for serious ailments, his patents represent a commitment to improving patient outcomes. As his career progresses, it will be exciting to see the future contributions he will make to the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile